Abstract
Objective
Incidence rates of oropharyngeal squamous cell carcinoma (SCC) have been reported to be increasing in several countries in recent decades, contrasting with trends of SCCs diagnosed in neighboring anatomical sites. We investigated whether changes in classification systems and/or coding/registration practices might explain the trends in Norway, focusing on changes in oropharyngeal cancer.
Methods
Trends in cancers of the oropharynx, base of tongue, nasopharynx, hypopharynx were graphically presented for the period 1981–2005, before and after recoding. Age-period-cohort and future prediction models were fitted to oropharyngeal SCC incidence.
Results
A total of 85 (3.7%) of the 2315 pharyngeal cancers required recoding. Rates of oropharyngeal cancer in Norway were consistently two to three times higher in men, with rapid increases in both men (5% per annum) and women (4.2% per annum). Assuming generational effects, male cohorts born 1915–1950 were at increasingly higher risk of the disease. The number of oropharyngeal cancer cases is expected to double in Norway by 2020.
Conclusions
The trends were not considered materially biased by potential artefacts. The increasingly higher proportion of oropharyngeal SCC cancers is more likely explained by other factors, including an increasing high-risk HPV prevalence among recent cohorts. These results will likely have consequences on treatment and health care provision in the near future.
Similar content being viewed by others
References
Nasman A, Attner P, Hammarstedt L et al (2009) Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 125:362–366
Syrjanen S (2004) HPV infections and tonsillar carcinoma. J Clin Pathol 57:449–455
Hammarstedt L, Dahlstrand H, Lindquist D et al (2007) The incidence of tonsillar cancer in Sweden is increasing. Acta Otolaryngol 127:988–992
Robinson KL, Macfarlane GJ (2003) Oropharyngeal cancer incidence and mortality in Scotland: are rates still increasing? Oral Oncol 39:31–36
Chaturvedi AK, Engels EA, Anderson WF, Gillison ML (2008) Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 26:612–619
Frisch M, Hjalgrim H, Jaeger AB, Biggar RJ (2000) Changing patterns of tonsillar squamous cell carcinoma in the United States. Cancer Causes Control 11:489–495
Sturgis EM, Cinciripini PM (2007) Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 110:1429–1435
Braakhuis BJ, Visser O, Leemans CR (2009) Oral and oropharyngeal cancer in The Netherlands between 1989 and 2006: Increasing incidence, but not in young adults. Oral Oncol 45:e85–e89
Mork J, Glattre E (1998) Squamous cell carcinomas of the head and neck in Norway, 1953–1992: an epidemiologic study of a low-risk population. Cancer Causes Control 9:37–48
D’Souza G, Kreimer AR, Viscidi R et al (2007) Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356:1944–1956
Gillison ML, Koch WM, Capone RB et al (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92:709–720
Herrero R, Castellsague X, Pawlita M et al (2003) Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 95:1772–1783
Mork J, Lie AK, Glattre E et al (2001) Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 344:1125–1131
Applebaum KM, Furniss CS, Zeka A et al (2007) Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer. J Natl Cancer Inst 99:1801–1810
Gillison ML, D’Souza G, Westra W et al (2008) Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 100:407–420
Larsen IK, Smastuen M, Johannesen TB et al (2009) Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer 45:1218–1231
Mork J, Thoresen S, Faye-Lund H, Langmark F, Glattre E (1995) Head, neck cancer in Norway. A study of the quality of the Cancer Registry of Norway’s data on head, neck cancer for the period 1953–1991. APMIS 103:375–382
Doll R, Cook P (1967) Summarizing indices for comparison of cancer incidence data. Int J Cancer 2:269–279
Segi M, Kurihara M (1960) Cancer mortality for selected sites in 24 countries (1950–1957). Tohoku University of Medicine, Sendai, p 1
Holford TR (1983) The estimation of age, period and cohort effects for vital rates. Biometrics 39:311–324
Clayton D, Schifflers E (1987) Models for temporal variation in cancer rates. I: Age-period and age-cohort models. Stat Med 6:449–467
Holford TR (1998) Age-period-cohort analysis. Encyclopedia of biostatistics. Wiley, Chichester, pp 82–99
Clayton D, Schifflers E (1987) Models for temporal variation in cancer rates. II: age-period-cohort models. Stat Med 6:469–481
Moller B, Fekjær H, Hakulinen T et al (2003) Prediction of cancer incidence in the Nordic countries: empirical comparison of different approaches. Stat Med 22:2751–2766
StataCorp (2009) Stata statistical software. StataCorp LP, College Station
R Development Core Team (2008) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
Cook MB, Dawsey SM, Freedman ND et al (2009) Sex disparities in cancer incidence by period and age. Cancer Epidemiol Biomarkers Prev 18:1174–1182
Bray FI, Weiderpass E (2010) Lung cancer mortality trends in 36 European countries: secular trends and birth cohort patterns by sex and region 1970–2007. Int J Cancer 126:1454–1466
Bray F, Loos AH, McCarron P et al (2005) Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomarkers Prev 14:677–686
Phillips J, Hilger A (2009) Surgery: are we performing enough tonsillectomies? Nat Rev Clin Oncol 6:439–440
Fakhry C, Gillison ML (2006) Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncol 24:2606–2611
Schwartz SM, Daling JR, Doody DR et al (1998) Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst 90:1626–1636
Fakhry C, Westra WH, Li S et al (2008) Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100:261–269
Ragin CC, Taioli E (2007) Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer 121:1813–1820
Financial support: None.
Conflict of interest’s statement: None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mork, J., Møller, B., Dahl, T. et al. Time trends in pharyngeal cancer incidence in Norway 1981–2005: a subsite analysis based on a reabstraction and recoding of registered cases. Cancer Causes Control 21, 1397–1405 (2010). https://doi.org/10.1007/s10552-010-9567-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-010-9567-9